CONSOLIDATED BALANCE SHEETS (USD $)	Nov. 30, 2013	Nov. 30, 2012
Current assets
Cash and cash equivalents	$ 146,205	$ 199,472
Other current assets	32,600	11,293
Total current assets	178,805	210,765
Property and equipment, net of accumulated depreciation of $40,561	0	0
Other assets	280	280
Total assets	179,085	211,045
Current liabilities
Accounts payable and accrued expenses	1,072,521	1,106,177
Payable to related party	50,000	50,000
Advance from warrant holder	61,950	50,000
Convertible debentures	45,146	0
Current portion of deferred revenue	49,318	49,318
Total current liabilities	1,278,935	1,255,495
Non-current liabilities
Convertible debentures	0	56,026
Deferred revenue, net of current portion	449,424	498,741
Derivative liability related to Series B convertible preferred stock	18,147	19,245
Total non-current liabilities	467,571	574,012
Total liabilities	1,746,506	1,829,507
Commitments and contingencies
MultiCell Technologies, Inc. equity (deficiency)
Preferred stock	0	0
Common stock, $0.01 par value; 5,000,000,000 shares authorized; 2,610,793,503 and 1,349,803,029 shares issued and outstanding at November 30, 2013 and 2012, respectively	26,107,935	13,498,030
Additional paid-in capital	16,556,524	27,755,595
Accumulated deficit	(43,489,211)	(42,254,594)
Total MultiCell Technologies, Inc. stockholders' equity (deficiency)	(362,917)	(539,134)
Noncontrolling interests	(1,204,504)	(1,079,328)
Total equity (deficiency)	(1,567,421)	(1,618,462)
Total liabilities and equity (deficiency)	179,085	211,045
Series B Convertible Preferred Stock [Member]
MultiCell Technologies, Inc. equity (deficiency)
Preferred stock	461,835	461,835
Total equity (deficiency)	461,835	461,835
Series I Convertible Preferred Stock [Member]
MultiCell Technologies, Inc. equity (deficiency)
Preferred stock	0	0
Total equity (deficiency)	$ 0	$ 0